Rhythm Pharmaceuticals

-$0.34 (-7.26%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RYTM and other ETFs, options, and stocks.

About RYTM

Rhythm Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in developing and commercializing peptide therapeutics for the treatment of gastrointestinal diseases and genetic deficiencies. The firm focuses on the treatment for Prader-Willi Syndrome and Pro-Opiomelanocortin deficiency obesity.

CEO
David P. Meeker
Employees
140
Headquarters
Boston, Massachusetts
Founded
2008

RYTM Key Statistics

Market cap
218.71M
Price-Earnings ratio
—
Dividend yield
—
Average volume
3.05M
High today
$4.68
Low today
$4.28
Open price
$4.68
Volume
405.26K
52 Week high
$20.84
52 Week low
$3.04

RYTM News

MarketWatchJun 22

Rhythm Pharmaceuticals Shares Advance After European Drug News - MarketWatch

By Dean Seal Shares of Rhythm Pharmaceuticals Inc. rose 7.6% to $4.52 by midday Wednesday after the company said its obesity treatment is now available to pati

RYTM Earnings

-$1.05
-$0.70
-$0.35
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 2, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure